Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Astrana Health, Inc. (ASTH) had Revenue of $2.03B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$2.03B
Net Income	$43.15M
Cost of Goods Sold	$1.76B
Gross Profit	$271.39M
Operating Expenses	$1.95B
Operating Income	$89.35M
Non-Operating Income/Expense	$-8.53M
Pre-Tax Income	$80.82M
Normalized Pre-Tax Income	$80.09M
Income after Taxes	$49.93M
Income from Continuous Operations	$49.93M
Consolidated Net Income/Loss	$49.93M
Normalized Income after Taxes	$48.92M
EBIT	$89.35M
EBITDA	$119.11M
Weighted-Average Shares Outstanding (Basic)	47.60M
Weighted-Average Shares Outstanding (Diluted)	47.97M
Earnings per Share (EPS) (Basic)	$0.91
Earnings per Share (EPS) (Diluted)	$0.90
Balance Sheet Financials
Current Assets	$638.50M
Property, Plant, and Equipment	$14.27M
Long-Term Assets	$716.40M
Total Assets	$1.35B
Current Liabilities	$365.61M
Long-Term Debt	$425.91M
Long-Term Liabilities	$272.56M
Total Liabilities	$638.17M
Common Equity	$716.73M
Tangible Shareholders Equity	$179.29M
Shareholders Equity	$716.73M
Common Shares Outstanding	47.93M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$52.20M
Cash Flow from Investing Activities	$-192.40M
Cash Flow from Financial Activities	$135.15M
Beginning Cash	$294.15M
End Cash	$289.10M
Increase/Decrease in Cash	$-5.05M
Stock-Based Compensation	$34.54M
Common Stock Dividends Paid	$-4.08M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.75
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.37
Debt to Equity Ratio	0.61
Gross Margin	13.34%
Operating Margin	4.39%
EBIT Margin	4.39%
EBITDA Margin	5.85%
Pre-Tax Profit Margin	3.97%
Profit Margin	2.12%
Free Cash Flow	$44.17M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.50
Inventory Turnover	--
Receiveable Turnover	6.26
Days Sales in Receivables	58.27
Return on Equity	6.97%
Return on Tangible Equity	27.85%
Return on Assets	3.69%
Return on Investments	4.37%
Book Value Per Share	$14.95
Free Cash Flow per Share	$0.92
Operating Cash Flow per Share	$1.09

Data from Zacks Investment Research, Inc.